bal Equities Insurance Fund Two Ocean Capital LP 129. Vida Insurance Fund Vida Capital Management, LLC 130. William Blair Dynamic Insurance Fund William Blair & Company, L.L.C. 131. Yield Opportunities (Insurance Dedicated) Fund Goldman Sachs Asset Management, L.P. Multi-Manager Insurance-Dedicated Funds Investme

William Blair & Company, LLC. Exhibit 1 ARIAD Pharmaceuticals, Inc. Sum-of-Parts Fair Value (dollars in thousands) Drug Peak Sales Stage of Development Estimated L

William Blair & Company, LLC • The REMS program will consist of a communication plan to better educate patients and prescribers about the increased risk of occlusions and

TDA (TIM) -256.8 Enterprise Value/EBrIDA (TTM) -3.8x Return on Equity (TIM) -132.7 Tivo-Year Price Performance Chart Tz ti `mounts: radtict. William Blair & Company cstimatcs Please consult pages 7-8 of this report for all disclosures. Analyst certification is on page 7. William Blair 8 Company, L.L.C. does an

William Blair & Company, L LC. MPORTANT DISCLOSURES William Blair is a market maker in the security of ARIAD Pharmaceuticals, Inc. and may have a long or short position.

William Blair & Company, L LC. Exhibit 2 ARIAD Pharmaceuticals, Inc. Income Statement (dollars in millions) 2011 FY:11A 2012 FY:12A CI1A 02A 2013 C13A 04E FY:1